Glossy ganoderma spore oil promotes apoptosis of human lung adenocarcinoma SPC-A1 through downregulation of miR-21

Zhongguo Zhongyao Zazhi

Volumn 36, Issue 9, 2011, Pages 1231-1234

  Zhao, Guangfeng ^a   Guo, Wei ^a   Zhao, Xiaoyin ^a   Wang, Yaping ^a   Hou, Yayi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Apoptosis; Glossy ganoderma spore oil; miR 21; SPC A1; Tumor suppressor

Indexed keywords

GANODERMA SPORE OIL; MICRORNA 21; UNCLASSIFIED DRUG; VEGETABLE OIL;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; DOWN REGULATION; FLOW CYTOMETRY; GANODERMA; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PROTEIN EXPRESSION; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; GANODERMA; HUMANS; LUNG NEOPLASMS; MICRORNAS; POLYMERASE CHAIN REACTION; SPORES, FUNGAL;

EID: 80051538326     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20110926     Document Type: Article

References (14)

1. Wargovich M J, Woods C, Hollis D M, et al. Herbals cancer prevention and health [J]. J Nutr, 2001,131(11):3034.
2. Seikea M, Gotoa A, Okanoa T, et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers [J]. PNAS, 2009,106(29):12085.
3. Asangani I A, Rasheed S A K, Nikolova D A, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer [J]. Oncogene, 2008(27):2128.
4. Zhang J G, Wang J J , Zhao F, et al. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC) [J]. Clin Chimica Acta, 2010,411:846.
5. Cmarik J, Min H, Hegamyer G, et al. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation [J]. Proc Natl Acad Sci USA, 1999,96:14037.
6. Jan sen A P,amalier C E, Stark C, et al. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity [J]. Mol Cancer Ther, 2004,3(2):103.